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Abstract
The Hippo pathway was discovered as a conserved tumour suppressor pathway restricting cell 
proliferation and apoptosis. However, the upstream signals that regulate the Hippo pathway in the 
context of organ size control and cancer prevention are largely unknown. Here, we report that 
glucose, the ubiquitous energy source utilised for ATP generation, regulates the Hippo pathway 
downstream effector YAP. We show that both the Hippo pathway and AMP-activated protein 
kinase (AMPK) were activated during glucose starvation, resulting in phosphorylation of YAP and 
contributing to its inactivation. We also identified glucose-transporter 3 (GLUT3) as a YAP-
regulated gene involved in glucose metabolism. Together, these results demonstrate that glucose-
mediated energy homeostasis is an upstream event involved in regulation of the Hippo pathway 
and, potentially, an oncogenic function of YAP in promoting glycolysis, thereby providing an 
exciting link between glucose metabolism and the Hippo pathway in tissue maintenance and 
cancer prevention.
INTRODUCTION
The Hippo pathway was initially identified through genetic screening in Drosophila as 
having crucial roles in restricting tissue growth1–3. The evolutionarily conserved functions 
of this pathway in control of tissue and organ size were further demonstrated through 
genetically engineered mouse models. In mammalian systems, the Hippo pathway is 
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composed of core kinase complexes (MST1/2 and LATS1/2), adaptor proteins (SAV1 for 
MST1/2 and MOB1 for LATS1/2), downstream effectors (YAP and TAZ) and nuclear 
transcription factors (TEAD1/2/3/4). MST1/2 kinase phosphorylates and activates LATS1/2 
kinases. Active LATS1/2 phosphorylates YAP at Serine 127 (S127) and provides the 
docking site for the 14-3-3 protein, which sequesters YAP in cytoplasm. Moreover, 
LATS1/2 phosphorylates YAP at S381, which leads to YAP degradation through the β-
TRCP E3 ligase complex4. Un-phosphorylated YAP translocates into the nucleus and 
functions as a transcriptional co-activator by binding to the TEAD family of transcription 
factors. The YAP-TEAD complex regulates transcription of genes that promote proliferation 
and inhibit apoptosis, two key events for organ size control. Nuclear protein VGLL4 directly 
competes with YAP for binding to TEAD transcription factors and consequently inhibits 
YAP’s transcriptional functions5,6.
Notably, ablation of Hippo pathway components leads to tumour formation7–9, which 
suggested that the Hippo pathway is a tumour suppressor pathway. As the major target of 
the Hippo pathway, YAP has been identified as an oncogene. Transgenic expression of YAP 
in mouse liver reversibly enlarged livers and eventually led to tumour formation10,11. 
Moreover, downregulation of Hippo pathway components and elevated activation of 
YAP/TAZ have been observed in various human cancers11,12, which further demonstrates 
the critical roles of the Hippo pathway in human cancer prevention.
Many studies in recent years have been devoted to identification of upstream regulators of 
the Hippo pathway in order to elucidate the mechanisms underlying organ size control. 
These studies uncovered many components of cell adhesion junction and tight junction as 
Hippo pathway regulators, findings that agree with the known cell density–dependent 
regulation of the Hippo pathway13. Cytoskeleton-mediated mechanical force also plays a 
key role in YAP regulation14–16. Moreover, G-protein-coupled receptors function upstream 
of the Hippo pathway through Rho GTPase and cytoskeleton remodeling17. However, the 
upstream signals that regulate the Hippo pathway in the context of organ size control and 
cancer prevention are still largely unknown.
In this study, we identified crosstalk between glucose metabolism and the Hippo pathway. 
The energy stress generated by a defect in glucose metabolism activated LATS kinase and 
AMPK kinase leading to phosphorylation of YAP and inhibition of its cellular functions. On 
the other hand, YAP promoted glucose metabolism through upregulation of glucose 
transporter 3 (GLUT3) expression at the transcriptional level. These findings revealed a 
critical crosstalk between energy homeostasis and the Hippo pathway underlining metabolic 
control of the Hippo pathway and a previously unknown function of the Hippo pathway in 
glucose metabolism.
RESULTS
Glucose homeostasis regulates YAP phosphorylation and localisation
We explored whether any growth condition might control activation of the Hippo pathway 
and found that glucose starvation increased phosphorylation of YAP at S127 (Figure 1A), 
the major phosphorylation site regulated by the Hippo pathway. When glucose was added 
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back to glucose-deprived cells, the phosphorylation of YAP at S127 dramatically decreased 
(Figure 1A). This glucose-stimulated effect was transient, since the phosphorylation of YAP 
gradually recovered after 2 hours or longer (Figure 1A). The levels of YAP upstream 
kinases LATS1 and MST1 were not affected by glucose (Figure 1A), while this glucose 
switch, as expected, regulated phosphorylation of ACC and activation of S6K, AKT and 
ERK (Figure 1A).
To further validate these findings, glucose-starved cells were given different types of 
glucose-containing medium: regular glucose-rich medium (25 mM glucose), or glucose-free 
medium containing either D-glucose (25 mM) or 2-deoxy-D-glucose (2-DG, 25 mM). 2-DG 
is a glucose molecule that has the 2-hydroxyl group replaced by hydrogen, so that it fails to 
undergo further glycolysis and therefore leads to energy stress due to reduced ATP 
production. The phosphorylation of YAP decreased in cells stimulated by the regular 
glucose-rich medium or the D-glucose–containing medium, but not in cells stimulated by 2-
DG–containing medium (Figure 1B). The subcellular localisation of YAP corresponded to 
its phosphorylation status: YAP localised mostly in cytoplasm in glucose-starved cells 
(Figure 1C), and while glucose-rich medium and D-glucose–containing medium induced 
nuclear translocation of YAP, YAP was retained in the cytoplasm in cells cultured with 2-
DG–containing medium (Figure 1C). These data suggest that glucose status regulates YAP 
phosphorylation and subcellular localisation.
To determine the role of 2-DG in YAP regulation, cells were treated transiently with glucose 
starvation, 2-DG or a combination. The combination increased YAP phosphorylation to a 
greater extent than 2-DG treatment alone (Figure 1D). Moreover, the effect of 2-DG 
treatment on YAP was dose dependent (Figure 1E). These data indicate that a 2-DG-induced 
defect in glucose metabolism could inhibit YAP function.
Release of energy stress activates YAP
Glucose is widely used as an energy source in various organisms, and defects in glucose 
metabolism create energy stress in the cell18,19. To further address the role of energy stress 
in YAP function, we employed three different methods to induce energy stress in cells: 
glucose starvation, treatment with 2-DG, and treatment with 5-amino-1-β-D-ribofuranosyl-
imidazole-4-carboxamide (AICAR). AICAR is phosphorylated by adenosine kinase to form 
ZMP, an analog of AMP, thereby mimicking energy stress conditions with a high AMP 
level. Under all three of these conditions, YAP localised mostly in the cytoplasm in both 
HEK293A and MCF10A cells (Figure 2A). Notably, however, YAP translocated into the 
nucleus when cells were released from energy stress (Figure 2A). The decrease of YAP 
phosphorylation upon release from energy stress was observed by both Western blotting 
with YAP phospho-specific antibody (S127) and the migration shift of YAP in phospho-tag 
gel (Figure 2B). Consistent with these findings were the observations that release from 
energy stress diminished YAP’s association with the 14-3-3 protein, while increasing its 
interaction with TEAD1 (Figure 2C). Accordingly, release from energy stress also increased 
the transcription of YAP downstream target genes CTGF, CYR61 and ANKRD1 (Figure 2D), 
indicating that release from energy stress activates YAP.
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We also investigated YAP activity in liver samples obtained from mice that had fasted for 
16 hours and then were fed or fasted for another 5 hours. YAP was less phosphorylated in 
the liver samples from fed mice than in those from fasting mice (Figure 2E). Moreover, in 
the livers of fed mice, YAP translocated into nucleus (Figure 2F) and promoted transcription 
of its downstream target genes (Figure 2G). These results indicate the physiological 
relevance of energy homeostasis in the regulation of YAP activity.
AMPK associates with and phosphorylates YAP
To identify the mechanisms underlying the regulation of YAP by energy stress, we isolated 
YAP-associated protein complexes in glucose-starved HEK293A cells through tandem 
affinity purification followed by mass spectrometry analysis. Surprisingly, the AMPK α and 
β subunits were identified on the prey list (Figure 3A). The specific interaction between 
AMPK and YAP was confirmed by pulldown assays (Figures 3B and 3C). Co-expression of 
YAP with an AMPKα1 C terminal–truncated mutant (amino acids 1–312), which has been 
demonstrated to be a constitutively active form of AMPK20,21, but not with its inactive 
counterpart (T172A), induced YAP migration shift in phospho-tag gel (Figure 3D), 
suggesting that YAP is phosphorylated by AMPK in vivo. Since AMPK is a master regulator 
of energy homeostasis and is activated by energy stress, our results indicate that AMPK may 
directly phosphorylate YAP in response to energy stress.
AMPK phosphorylates YAP on several residues including the S61 site
In searching for AMPK phosphorylation sites on YAP, we again used mobility shift in 
phospho-tag gel to assess YAP phosphorylation. We found that the YAP-5SA mutant13 
could not be phosphorylated as dramatically as wild-type YAP by the active AMPK 
truncation mutant (Figure 4A), which indicated that one or more of these mutated serine 
residues is the AMPK phosphorylation site(s). The YAP-5SA mutant was originally 
generated to mutate all of the putative LATS kinase phosphorylation sites on YAP4,13,22. 
We sequenced this mutant and confirmed that it comprises eight serine sites mutated to 
alanine (Figure 4B). Mutation of each alanine back to serine generated six different 
YAP-4SA mutants, and of these only YAP-4SA-61S could be intensely phosphorylated by 
AMPK as evaluated by phospho-tag gel analysis (Figure 4C). The YAP-S61A mutant could 
not be strongly phosphorylated by AMPK in the same experiments (Figure 4D), indicating 
that the YAP S61 site is an AMPK phosphorylation site.
We also performed in vitro kinase assays and analysed YAP phosphorylation site(s) by mass 
spectrometry as an independent method to identify AMPK phosphorylation sites. We again 
uncovered S61, as well as two other sites (S94 and T119), as AMPK phosphorylation sites 
(Supplementary Figure 1 and Supplementary Table 1), suggesting that AMPK may 
phosphorylate S61 as well as other sites on YAP. These data agree with the observation that 
energy stress was capable of inducing a mild shift of the YAP-5SA mutant in phospho-tag 
gel (Supplementary Figure 2A).
To further confirm that S61 is an AMPK phosphorylation site, we generated YAP S61 
phospho-specific antibody and validated its specificity in vitro and in vivo (Supplementary 
Figures 2B–2D). Using this antibody, we showed that YAP S61 phosphorylation increased 
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following 2-DG treatment in wild-type mouse embryonic fibroblasts (MEFs) but not in 
AMPK-knockout MEFs (Figure 4E), suggesting that AMPK phosphorylates YAP at the S61 
site in response to energy stress. Notably, the S61 site is evolutionarily conserved (but not in 
Drosophila) and shows some similarity to the consensus AMPK phosphorylation site 
(Supplementary Figure 2E).
AMPK phosphorylates YAP in parallel with the Hippo pathway
Although YAP S127 phosphorylation increased following energy stress (Figure 1), AMPK 
did not appear to be the major contributor to the phosphorylation of YAP at the S127 site 
(Figure 4F). LATS1 phosphorylation and MST1 phosphorylation were not significantly 
affected by the active AMPK truncation mutant (Supplementary Figures 3A and 3B). 
Moreover, LATS1 kinase activation induced by 2-DG treatment was not dramatically 
different in wild-type or AMPK knockout MEFs (Figure 4G and Supplementary Figure 3C). 
These results indicate that energy stress activates the Hippo pathway in a manner that is 
largely independent of AMPK. The S61 site was previously predicted to be a LATS 
phosphorylation site4,13,22. However, the Hippo core kinase complex could phosphorylate 
only the YAP-4SA-127S mutant but not the YAP-4SA-61S mutant (Figure 4H). These 
results indicate that energy stress may activate two parallel cellular signaling pathways, 
AMPK and the Hippo pathway, which phosphorylate YAP at least at the S61 and S127 sites, 
respectively.
AMPK-mediated YAP phosphorylation inhibits YAP transcriptional activity
Previous studies suggested that phosphorylation of YAP increased its interaction with the 
14-3-3 protein, which sequesters YAP in the cytoplasm11,13,22. The 5SA mutant of YAP 
blocked YAP’s association with the 14-3-3 protein, translocated YAP into the nucleus and 
increased YAP transcriptional functions11,13,22. Since the YAP S61 site is among the 
putative phosphorylation sites mutated in the 5SA mutant, we first examined whether 
AMPK would affect the interaction between YAP and the 14-3-3 protein. AMPK-mediated 
YAP phosphorylation did not increase the association of YAP with 14-3-3 (Supplementary 
Figure 4A). The S127 site, but not the S61 site, was the binding site for the 14-3-3 protein 
(Supplementary Figures 4B and 4C). The active AMPK truncation mutant did not change 
YAP localisation (Supplementary Figure 4D), and the YAP S61 mutant did not regulate 
YAP nuclear localisation (Supplementary Figure 4E). However, we noticed that the S61A 
single mutation increased the transcription of YAP downstream target genes (CTGF and 
CYR61) (Figure 4I). These data suggest that YAP transcriptional activity was suppressed by 
S61 phosphorylation, although the binding between YAP and TEAD was not noticeably 
affected by the phospho-mimetic mutant of the S61 site (S61D) (Supplementary Figure 4F). 
Exactly how AMPK-dependent S61 phosphorylation inhibits YAP transcriptional activity 
remains unknown. It is possible that this AMPK-dependent phosphorylation at the YAP S61 
site may affect the binding of YAP with some yet unknown proteins required for YAP 
activity, and we are now investigating this hypothesis.
On the other hand, the YAP S94 site was also identified as an AMPK phosphorylation site 
(Supplementary Figure 1 and Supplementary Table 1), and the phospho-mimetic mutant of 
this site (S94D) greatly diminished YAP-TEAD interaction (Supplementary Figure 4F). 
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Moreover, a single phospho-mimetic mutation of either S61 or S94 suppressed YAP 
transcriptional activity, and the combined phospho-mimetic mutation of both sites further 
suppressed it (Supplementary Figure 4G). These data indicate that AMPK may inhibit YAP 
transcriptional activities by phosphorylating multiple sites on YAP.
To further confirm the suppressive role of AMPK in YAP regulation, we examined YAP 
transcriptional activity in wild-type or AMPK-deficient MEFs. The transcription of YAP 
downstream genes was elevated in AMPK-knockout MEFs (Figure 4J). Moreover, loss of 
AMPK attenuated the relative suppressive effect on YAP induced by 2-DG compared to that 
in control MEFs (Figure 4K). Together, these results indicate that AMPK is a negative 
regulator of YAP in response to energy stress.
Energy stress activates LATS kinase but not MST kinase in the Hippo pathway
The observation that energy stress regulated YAP S127 phosphorylation (Figure 1) indicates 
that the Hippo pathway was also activated by energy stress. Interestingly, 2-DG treatment 
increased LATS1 kinase phosphorylation (T1079) (Figure 5A) but not MST1 kinase 
phosphorylation (T183) (Figure 5B). Release from energy stress rapidly decreased the 
LATS1 phosphorylation but not MST1 phosphorylation (Figure 5C). Moreover, YAP S127 
phosphorylation was increased by 2-DG in MST1/2 double-knockout cells (Figure 5D). 
These data indicate that energy stress induces YAP S127 phosphorylation through activation 
of LATS kinases but not MST kinases in the Hippo pathway.
Energy stress induces LATS kinase activation mainly through Rho GTPase and 
cytoskeleton
Previous studies suggested that Rho GTPase–mediated remolding of actin cytoskeleton 
could inhibit LATS kinase and activate YAP independent of MST kinase14,17. We therefore 
examined the roles of actin cytoskeleton and Rho GTPase in energy stress–regulated YAP 
phosphorylation. In cells released from energy stress, latrunculin B–mediated actin 
depolymerisation reversed the decrease of YAP S127 phosphorylation (Figure 5E). Rho 
GTPase inhibitor C3 also rescued the decrease of YAP S127 phosphorylation (Figure 5E). 
Furthermore, release from energy stress increased the Rho GTPase activity (GTP-formed 
Rho) (Figure 5F). Although detailed mechanisms are still unclear, several studies have 
shown that the activity of Rho GTPase is regulated by glucose treatment23–25, which is 
consistent with our findings presented in Figure 5F. Thus, energy stress may activate LATS 
kinases by modulating Rho GTPase activity. It remains to be determined whether actin 
cytoskeleton plays a direct and specific role in this process.
Active YAP promotes glycolysis
The results presented so far established a connection between glucose homeostasis and the 
regulation of YAP. The next question is the functional significance of this regulation. We 
noticed, interestingly, that the culture medium for YAP-5SA cells quickly turned yellow 
compared with the culture media for the vector control cells, the wild-type YAP cells or the 
TEAD non-binding mutant YAP-S94A26 cells (Figure 6A), although the numbers of cells in 
each culture were similar. The yellow colour of the medium indicated that it had been 
acidified and the level of glycolysis increased in these cells27. Indeed, the YAP-5SA 
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medium showed a lower pH value but higher glucose uptake and lactate production than 
media from other cell lines (Figures 6B–6D). These data suggest that YAP is involved in the 
glucose metabolism pathway and that this involvement is likely mediated by its target genes.
YAP up-regulates GLUT3 in glucose metabolism pathway
To identify YAP regulated genes involved in glucose metabolism, we examined the 
transcription of a panel of glucose metabolism–related genes in cells expressing the 
YAP-5SA mutant and in vector-control cells. The analysis showed that GLUT3 transcription 
was much higher in YAP-5SA cells than in vector-control cells (Figure 6E). The 
dependence on YAP transcriptional activity was confirmed in YAP-5SA-S94A cells, in 
which GLUT3 transcription decreased (Figure 6F). Similar findings were obtained from 
other cell lines (Figures 6G and 6H). Furthermore, a higher level of GLUT3 protein was 
detected in YAP-5SA cells than in other cells by Western blotting (Figures 6I and 6J). 
Down-regulation of YAP (Figure 6K) suppressed the increase of GLUT3 transcription in 
cells released from energy stress (Figure 6L). We identified a conserved TEAD-binding site 
in the GLUT3 promoter, and ENCODE data showed that this site was bound by TEAD 
(Supplementary Figure 5). These results indicate that YAP-TEAD may directly regulate the 
transcription of GLUT3. Moreover, results from two other studies26,28 suggested that the 
expression of GLUT3 was up-regulated by active YAP, which support our findings that 
YAP regulates GLUT3 expression.
To determine the role of GLUT3 in YAP-mediated glycolysis, we knocked down GLUT3 in 
YAP-5SA cells (Figure 6M) and found that this down-regulation of GLUT3 partially 
reversed medium acidification, glucose uptake and lactate production in cells expressing the 
YAP-5SA mutant (Figures 6N–6Q). These data suggest that GLUT3 is at least one of the 
downstream effectors involved in YAP-regulated glycolysis.
GLUT3 expression correlates with YAP protein level in human liver and colon cancers
Since high expression of GLUT3 has been identified in various types of cancers29–34, we 
examined expression of YAP and GLUT3 in samples of human cancer, specifically colon 
and liver cancers. Indeed, the expression of YAP and GLUT3 was higher in tumour samples 
than in normal tissues (Figure 7A), and their expressions were positively correlated in 
tumour samples (Figure 7B). These data indicate a potential role for YAP in regulating 
GLUT3 expression in human cancers.
DISCUSSION
In this study, we unexpectedly discovered that AMPK, the master kinase that senses the 
cellular AMP/ATP ratio, directly phosphorylates YAP and inhibits YAP transcriptional 
activity. We demonstrated that AMPK directly phosphorylates YAP at multiple sites and 
thus suppresses YAP transcriptional activity. We primarily investigated phosphorylation at 
S61 by AMPK, since this phosphorylation is the major event contributing to YAP migration 
shift on phospho-tag gel. We also noticed a minor shift of the YAP-5SA mutant on phospho-
tag gel, indicating that there are additional phosphorylation sites. Indeed, our mass 
spectrometry analysis supports these findings and revealed two more AMPK 
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phosphorylation sites on YAP, S94 and T119. The estimated phosphorylation on these three 
sites indicated that S61 (11.27%) and S94 (2.39%) are relatively dominant phosphorylation 
sites compared to T119 (0.53%). The S94 site is known to be required for YAP’s binding to 
TEAD and mutation of this site (S94A) abolishes TEAD-dependent YAP transcriptional 
activity26. The phospho-mimetic mutant of S94 (S94D) also inhibited the interaction 
between YAP and TEAD as well as transcription of YAP downstream target genes. In this 
issue, Guan and colleagues report similar findings about AMPK-dependent YAP 
phosphorylation on the S94 site, complementing our results (#35 Guan paper reference). 
Together, with their findings, our results suggest that AMPK may phosphorylate multiple 
sites on YAP and inhibit YAP transcriptional activity.
We also revealed that energy stress increases S127 phosphorylation and cytoplasmic 
localisation of YAP by activating the Hippo pathway. We explored the crosstalk between 
AMPK and the Hippo pathway, since both pathways are activated following energy stress. 
In LATS- or MST- deficient cells, AMPK activity, as indicated by ACC S79 
phosphorylation, was still increased by 2-DG treatment (Figure 5D), suggesting that AMPK 
is activated by energy stress independent of the Hippo pathway. On the other hand, 2-DG-
induced LATS kinase activation was slightly decreased in AMPK-knockout MEF cells 
(Figure 4G and Supplementary Figure 3C), indicating the involvement of both AMPK-
dependent and -independent pathways in the regulation of LATS kinase activity in response 
to energy stress. The AMPK-dependent regulation of the Hippo pathway is in agreement 
with recent finding that AMPK may activate the Hippo pathway by increasing the levels of 
angiomotin family proteins under energy stress36. Our findings showed that the AMPK-
independent pathway may be regulated by Rho GTPase, although the detailed mechanisms 
remain to be elucidated. Similar findings are reported by Guan and colleagues in this issue 
(#35 reference). Therefore, both AMPK and the Hippo pathway are activated following 
energy stress, which act together to suppress YAP activity (Supplementary Figure 6).
Our results demonstrated that the Hippo pathway is intimately associated with glucose 
homeostasis. This is highly significant since it establishes a connection between a pathway 
involved in organ size control and nutrient availability. The discovery of AMPK as a kinase 
for YAP, reported here, extends our understanding of YAP regulation outside of the classic 
Hippo pathway. The identification of GLUT3 as a YAP-regulated gene offers a potential 
link between the Hippo pathway and cancer metabolism. As hallmarks of cancer19, tumour 
cells are known to reprogram their signaling pathways and metabolism to support their 
uncontrolled proliferation and survival. Our study proposes yet another oncogenic function 
of YAP, via promotion of glucose uptake and glycolysis, which warrants further 
investigation.
METHODS
Antibodies
Anti-YAP antibody (1:1000 dilution) was raised by immunising rabbits with bacterially 
expressed and purified GST-fused human full-length YAP protein. Anti-AMOTL2 antibody 
(1:1000 dilution) was raised by immunising rabbits with bacterially expressed and purified 
GST-fused human AMOTL2 (amino acids 1~675). Antisera were affinity-purified by using 
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the AminoLink Plus immobilisation and purification kit (Pierce). Anti-YAP S61 phospho-
specific antibody (1:1000 dilution) was raised against keyhole limpet hemocyanin 
conjugated- phospho-peptide Biotin-QIVHVRGD(phospho-S)ETDLEALC, and anti-serum 
was affinity purified through SulfoLink peptide coupling gel. Additional anti-YAP 
(sc101199, 1:200 dilution for immunostaining) and anti-phospho-YAP (S127) (4911S, 
1:1000 dilution) antibodies were purchased from Santa Cruz Biotechnology and Cell 
Signaling Technology respectively. Anti-α-tubulin (T6199-200UL, 1:5000 dilution) and 
anti-flag (M2) (F3165-5MG, 1:5000 dilution) monoclonal antibodies were obtained from 
Sigma-Aldrich. Anti-Myc (sc-40, 1:1000 dilution), anti-GST (sc-138, 1:1000 dilution) and 
anti-14-3-3θ (sc-732, 1:1000 dilution) monoclonal antibodies were purchased from Santa 
Cruz Biotechnology. Anti-TEAD1 (610922, 1:1000 dilution) monoclonal antibody was 
obtained from Millipore. Anti-phosho-AKT1 (Ser473) (9271S, 1:1000 dilution), anti-
phospho-ERK1/2 (Thr202/Tyr204) (9100S, 1:1000 dilution), anti-phospho-ACC (Ser79) 
(3661S, 1:1000 dilution), anti-ACC (3662S, 1:1000 dilution), anti-phospho-p70 S6K 
(Thr389) (9205S, 1:1000 dilution), anti-phospho-AMPKα (Thr172) (2531S, 1:1000 
dilution), anti-AMPKα (2532S, 1:1000 dilution), anti-phospho-LATS1 (Thr1079) (8654S, 
1:1000 dilution), anti-LATS1(9153S, 1:1000 dilution and 3477S, 1:100 dilution for 
immunoprecipitation), anti-phospho-MST1 (Thr183)/MST2 (Ser180) (3681S, 1:1000 
dilution) and anti-MST1(3682S, 1:1000 dilution) polyclonal antibodies were purchased from 
Cell Signaling Technology. Anti-GLUT3 (sc-30107, 1:1000 dilution) polyclonal antibody 
was purchased from Santa Cruz Biotechnology. Anti-RhoA (ARH03-A, 1:1000 dilution) 
monoclonal antibody and GST-Rhotekin-RBD protein (RT01-A) were obtained from 
Cytoskeleton, Inc.
Constructs and viruses
All constructs were generated by polymerase chain reaction (PCR) and subcloned into 
pDONOR201 vector using Gateway Technology (Invitrogen) as the entry clones. As 
needed, the entry clones were subsequently recombined into gateway-compatible destination 
vectors for the expression of N- or C-terminal-tagged fusion proteins. pEBG-AMPKα1 
(amino acids 1–312) was purchased from Addgene (Plasmid #27632). pCMV-Flag YAP2 
5SA (Plasmid #27371), HA-MST2 (Plasmid #33098), HA-SAV1 (Plasmid #32834) and 
HA-MOB1 (Plasmid #32835) were all obtained from Addgene. PCR-mediated site-directed 
mutagenesis was used to generate serial point mutations as indicated. The GST-ACC (amino 
acids 1~130) construct was kindly provided by Dr. Zhijun Luo (Boston University).
HA-Flag–tagged retroviruses for various YAP mutants were generated by co-transfecting 
with pCL-Ampho packaging vector in the BOSC23 cell line. Cells were infected twice by 
0.45 μm–filtered retrovirus with the addition of polybrene (8 μg/mL) and selected with 
puromycin (2 μg/mL). Pooled stable cells were used for all the experiments after validation 
by immunostaining and Western blotting.
The SFB-YAP lentiviral expression vector was generated by inserting the gateway response 
fragment (attR1-ccdB-attR2)–fused SFB tag into the XbaI and SwaI multi-clonal sites of the 
pCDH-CMV-EF1-GFP vector (kindly provided by Dr. M. James You, MD Anderson 
Cancer Center). YAP was cloned into this vector through a gateway-based LR reaction. 
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YAP shRNA1 (Plasmid# 27368) and shRNA2 (Plasmid# 27369) were obtained from 
Addgene. GLUT3 shRNAs (TRCN0000043615 and TRCN0000042880) were purchased 
from OpenBiosystem. All lentiviral supernatants were generated by transient transfection of 
293T cells with helper plasmids pSPAX2 and pMD2G (kindly provided by Dr. Zhou 
Songyang, Baylor College of Medicine) and harvested 48 hours after transfection. 
Supernatants were passed through the 0.45μm filter and used to infect cells with the addition 
of polybrene (8 μg/mL).
Cell culture and transfection
HEK293T and HeLa cells were purchased from American Type Culture Collection (ATCC) 
and maintained in Dulbecco modified essential medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS) at 37°C in 5% CO2 (v/v). HEK293A cells were kindly provided by 
Dr. Jae-Il Park (MD Anderson Cancer Center). MCF10A cells, purchased from ATCC, were 
kindly provided from Dr. Dihua Yu (MD Anderson Cancer Center). MCF10A cells were 
maintained in DMEM/F12 medium supplemented with 5 % horse serum, 200 ng/mL 
epidermal growth factor, 500 ng/mL hydrocortisone, 100 ng/mL cholera toxin and 10 μg/ml 
insulin at 37°C in 5% CO2 (v/v). SUM159 cells, purchased from ATCC, were kindly 
provided by Dr. Li Ma (MD Anderson Cancer Center) and maintained in F12 medium 
containing 5% FBS, insulin (5 μg/mL), hydrocortisone (1 μg/mL) and HEPES (10 mM). The 
MDA-MB-231 cells, purchased from ATCC, were kindly provided by Dr. Mien-Chie Hung 
(MD Anderson Cancer Center) and cultured in DMEM with 10% FBS. AMPKα-knockout 
MEFs and wild-type MEFs were kindly provided by Dr. Benoit Viollet (University Paris 
Descartes, Institut Cochin) and cultured in DMEM with 10% FBS. All culture media 
contained 1% penicillin and streptomycin antibiotics. Plasmid transfection was performed 
with the polyethylenimine reagent.
Tandem affinity purification of SFB-tagged protein complexes
HEK293A cells were infected twice with SFB-YAP lentivirus. Pooled cells stably 
expressing the tagged YAP were selected by culturing in medium containing puromycin (2 
μg/mL), and the protein expression was confirmed by immunostaining and Western blotting. 
Cells were washed once and cultured in glucose-free DMEM (Invitrogen) with 10% 
dialysed FBS (Gemini Bio-Products) for 18 hours.
For affinity purification, glucose-starved HEK293A cells were subjected to lysis in NETN 
buffer (100 mM NaCl, 20 mM Tris-Cl, 0.5 mM EDTA, 0.5 % Nonidet P-40) with protease 
and phosphatase inhibitors at 4°C for 20 minutes. Crude lysates were subjected to 
centrifugation (14,000 rpm) at 4°C for 15 minutes. Supernatants were incubated with 
streptavidin-conjugated beads (Amersham) for 4 hours at 4°C. The beads were washed three 
times with NETN buffer, and bound proteins were eluted with NETN buffer containing 
biotin (2 mg/mL; Sigma) overnight at 4°C. The elutes were incubated with S protein beads 
(Novagen) for 4 hours. The beads were washed three times with NETN buffer and subjected 
to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Protein bands 
were excised and subjected to mass spectrometry analysis (performed by the Taplin Mass 
Spectrometry Facility, Harvard Medical School).
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Mouse fasting experiment
Five-week old C57/B6 female mice were randomly assigned to fasting and fasting-feed 
groups. The animal experiments were performed in accordance with a protocol approved by 
the Institutional Animal Care and Use Committee (IACUC) of MD Anderson Cancer 
Center. Mice that had fasted for 16 hours were then fed (n=3) or fasted (n=3) for another 5 
hours. Livers from these animals were collected and subjected to indicated experiments.
Immunofluorescent staining
Cells cultured on coverslips were fixed by 4% paraformaldehyde for 10 minutes at room 
temperature and then extracted with 0.5% Triton X-100 solution for 5 minutes. After 
blocking with Tris-buffered saline and Tween 20 solution containing 1% bovine serum 
albumin, cells were incubated with indicated primary antibodies for 1 hour at room 
temperature. After that, cells were washed and incubated with fluorescein isothiocyanate or 
rhodamine-conjugated second primary antibodies (1:3000 dilution, Jackson 
ImmunoResearch) for 1 hour. Cells were counterstained with 100 ng/mL 4′,6-diamidino-2-
phenylindole (DAPI) for 2 minutes to visualise nuclear DNA. The cover slips were mounted 
onto glass slides with anti-fade solution and visualised on a Nikon ECLIPSE E800 
fluorescence microscope with a Nikon Plan Fluor 60× oil objective lens (NA 1.30).
RNA extraction, reverse transcription and real-time PCR
RNA samples were extracted with TRIZOL reagent (Invitrogen). Reverse transcription 
assay was performed by using the ProtoScript M-MuLV Taq RT-PCR Kit (New England 
Biolabs) according to the manufacturer’s instructions. Real-time PCR was performed by 
using Power SYBR Green PCR master mix (Applied Biosystems). For quantification of 
gene expression, the 2−ΔΔCt method was used. GAPDH expression was used for 
normalisation. The sequence information for each primer used for gene expression analysis 
is as follows:
For human cell lines:
CTGF-Forward: 5′-CCAATGACAACGCCTCCTG-3′
CTGF-Reverse: 5′-GAGCTTTCTGGCTGCACCA-3′
CYR61-Forward: 5′-AGCCTCGCATCCTATACAACC-3′
CYR61-Reverse: 5′-GAGTGCCGCCTTGTGAAAGAA-3′
ANKRD1-Forward: 5′-CACTTCTAGCCCACCCTGTGA-3′
ANKRD1-Reverse: 5′-CCACAGGTTCCGTAATGATTT-3′
GAPDH-Forward: 5′-ATGGGGAAGGTGAAGGTCG-3′
GAPDH-Reverse: 5′-GGGGTCATTGATGGCAACAATA-3′
AMOTL2-Forward: 5′-AGCTTCAATGAGGGTCTGCT-3′
AMOTL2-Reverse: 5′-TGAAGGACCTTGATCACTGC-3′
GLUT3-Forward: 5′-TTGAACACCTGCATCCTTGA-3′
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GLUT3-Reverse: 5′-GACAGCCCATCATCATTTCC-3′
For mouse cell lines or tissues:
Amotl2-Forward: 5′-AGAGATTGGAATCGGCAAAC-3′
Amotl2-Reverse: 5′-TTCTCCTGTTCCTGTTGCTG-3′
Cyr61-Forward: 5′-ATGATGATCCAGTCCTGCAA-3′
Cyr61-Reverse: 5′-TAGGCTGTACAGTCGGAACG-3′
Gapdh-Forward: 5′-TGTTCCTACCCCCAATGTGT-3′
Gapdh-Reverse: 5′-TGTGAGGGAGATGCTCAGTG-3′
Acta2-Forward: 5′-AGGGCTGTTTTCCCATCCATCG-3′
Acta2-Reverse: 5′-TCTCTTGCTCTGGGCTTCATCC-3′
Ctgf-Forward: 5′-CAAGGACCGCACAGCAGTT-3′
Ctgf-Reverse: 5′-AGAACAGGCGCTCCACTCTG-3′
Glucose uptake assay
Cells were seeded in 10-cm dishes. Twenty-four hours later, cells were washed and 
refreshed with glucose-free DMEM with 10% dialysed FBS. Eighteen hours later, cells were 
treated with 2-NBDG (50 μM; Invitrogen) for 1 hour and washed with ice-cold phosphate-
buffered saline solution twice. Glucose uptake was quantified in the propidium iodide–
negative population of cells using fluorescence-activated cell sorting analysis.
Lactate production assay
Cells were seeded in 6-cm dishes. Forty-eight hours later, cell medium was removed and 
lactate concentration was determined by using Lactate Plus test strips and a Lactate Plus 
meter (Nova Biomedical). The cells remaining in the dish were harvested and counted by 
using a hemocytometer on a microscope. The rate of lactate production was calculated 
(lactate production = total lactate mole number/cell number).
Immunohistochemical analysis
Colon and liver tissue arrays were purchased from US Biomax. Samples were deparaffinised 
and rehydrated, and antigens were retrieved by applying Unmask Solution (Vector 
Laboratories) in a steamer for 30 minutes. To block endogenous peroxidase activity, the 
sections were treated with 1% hydrogen peroxide in methanol for 30 minutes. After 1 hour 
pre-incubation in 10% goat serum to prevent non-specific staining, the samples were 
incubated with an antibody to YAP (4912S, Cell Signaling Technology, 1:20 dilution) or 
GLUT3 (HPA006539, Sigma, 1:500 dilution) at 4°C overnight. The sections were incubated 
with SignalStain Boost Detection Reagent for 30 minutes at room temperature. Colour was 
developed with the SignalStain DAB Chromogen diluted solution (all reagents were 
obtained from Cell Signaling Technology). Sections were counterstained with Mayer 
hematoxylin. The correlation between YAP and GLUT3 and the correlation of YAP or 
GLUT3 with tissue type (normal versus cancer) were determined by the chi-square test.
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Statistical analysis
Each experiment was repeated twice or more, unless otherwise noted. No samples or 
animals were excluded from the analysis. For the mouse fasting experiment, no statistical 
method was used to predetermine sample size. The samples or animals were randomly 
assigned to different groups. A laboratory technician who provided animal care and 
collected the livers was blinded to the group allocation during all animal experiments and 
outcome assessment. Differences between groups were analysed by the Student t-test and 
Pearson chi-square analysis. A p value < 0.05 was considered statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Glucose homeostasis controls YAP phosphorylation and localization
(A) The phosphorylation of YAP was regulated by glucose deprivation and stimulation. 
HEK293A cells were glucose starved for the indicated intervals and then stimulated with 
glucose (25 mM) for the indicated intervals. Cell lysates from each time point were 
subjected to Western blotting. (B) Glucose but not 2-DG stimulated the dephosphorylation 
of YAP. Glucose starved HEK293A cells were released into 25mM glucose-containing 
Dulbecco modified essential medium (DMEM), glucose-free DMEM containing 25mM D-
glucose or glucose-free DMEM containing 25mM 2-DG. Cell lysates from each time point 
were subjected to Western blotting. (C) The localisation of YAP was detected by 
immunostaining with YAP monoclonal antibody in cells released from energy stress (as 
described for Figure 1B) for 1 hour. Scale bar=20 μm. The region inside each box was 
enlarged 2.5 times below. (D) 2-DG induced YAP phosphorylation. HEK293A cells were 
treated with each indicated medium for 4 hours. The D-glucose and 2-DG concentrations 
were 25 mM in each medium. (E) 2-DG-induced YAP phosphorylation was dose dependent. 
HEK293A cells were treated with glucose-free medium supplemented with 2-DG at 
indicated concentrations for 4 hours, and cell lysates representing each dose were subjected 
to Western blotting. Phospho-tag-containing gel (p-tag) was used to detect YAP 
phosphorylation. Uncropped images of Western blots are shown in Supplementary Figure 7.
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Figure 2. Release from energy stress activates YAP
(A) Energy stress was induced in HEK293A and MCF10A cells by glucose starvation or 
treatment with AICAR (0.5 mM) or 2-DG (25 mM) for 16 hours. Cells were released from 
energy stress for 1 hour and endogenous YAP localisation was detected by immunostaining 
with the YAP monoclonal antibody. Nuclei were visualized by Dapi staining. Scale bar=20 
μm. 2.5x enlargement of the boxed region is shown to the right of each image. (B) YAP 
phosphorylation decreased in cells released from energy stress. Lysates of HEK293A cells 
under one of the energy stresses (S) described in (a) or released from energy stress (R) for 1 
hour were subjected to Western blotting. YAP phosphorylation was detected by phospho-
tag-containing gel (p-tag). (C) Release from energy stress for 1 hour induced YAP-TEAD1 
association but suppressed YAP-14-3-3 interaction. (D) Release of cells from energy stress 
increased YAP transcriptional activity. YAP-regulated gene transcripts (CTGF, CYR61 and 
ANKRD1) were detected by quantitative PCR in cells under energy stress or released from 
energy stress for 2 hours and normalised (mean±s.d, n=3 biological replicates). * p<0.05, ** 
p<0.01 and *** p<0.001 (Student t-test). (E) YAP phosphorylation was higher in livers of 
fasting mice than in livers of mice fed after fasting. Mice that had fasted for 16 hours were 
then fed (n=3) or fasted (n=3) for another 5 hours. Livers were collected and subjected to 
lysis and Western blotting. The arrow indicates increasing YAP phosphorylation. (F) YAP 
translocated into nucleus in the liver of a fasting mouse after feeding. A liver from a fasting 
mouse and a liver from a mouse fed after fasting from (E) were randomly chosen for 
immunohistochemical staining with YAP antibody, followed by hematoxylin staining to 
visualise the nucleus. Scale bar=30 μm. The boxed region is enlarged below. (G) YAP 
transcriptional activity increased in fasting mouse liver after feeding. Transcription of YAP-
regulated genes (Ctgf, Cyr61, Acta2 and Amotl2) was detected by quantitative PCR in livers 
randomly chosen from mice in (E) (mean±s.d, n=3 biological replicates). * p<0.05 and ** 
p<0.01 (Student t-test). Statistics source data are shown in Supplementary Table 2. 
Uncropped images of Western blots are shown in Supplementary Figure 7.
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Figure 3. AMPK associates with and phosphorylates YAP
(A) AMPK kinase subunits were identified as YAP-associated proteins by tandem affinity 
purification–mass spectrometry in glucose-starved HEK293A cells. Bait protein is marked 
in red. Identified AMPKα1 and β1 subunits are marked in blue. The left column of numbers 
represents unique peptide number/total peptide number. The known YAP-associated 
proteins and the identified AMPK subunits are indicated. (B–C) YAP associated with 
AMPK. Indicated constructs were expressed in 293T cells for 24 hours, and cell lysates 
were subjected to pulldown assays with S protein beads. (D) AMPK phosphorylated YAP in 
vivo. GST-tagged rat AMPK (amino acids 1~312) or its kinase-dead mutant (T172A) was 
co-expressed with SFB-tagged YAP in 293T cells. The phosphorylation of YAP was 
assessed by phospho-tag gel (p-tag). Uncropped images of Western blots are shown in 
Supplementary Figure 7.
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Figure 4. AMPK phosphorylates YAP at S61 and suppresses its transcriptional activity
(A) AMPK active truncation mutant was co-expressed with indicated plasmids in 293T 
cells. The protein phosphorylation was assessed by phospho-tag gel (p-tag). (B) Schematic 
illustration of YAP protein domains and reported LATS kinase phosphorylation sites. The 
mutated serine sites in the YAP-5SA mutant are listed. (C) AMPK phosphorylated the 
YAP-4SA-61S mutant. AMPK active truncation mutant was co-expressed with indicated 
YAP-4SA mutants in 293T cells. (D) S61 was the AMPK phosphorylation site on YAP. 
AMPK active truncation mutant was co-expressed with YAP or YAP S61A mutant in 293T 
cells. The phosphorylation of YAP was assessed by phospho-tag gel (p-tag). (E) 2-DG 
induced AMPK-dependent YAP S61 phosphorylation. Wild-type MEFs (WT) and AMPKα-
knockout MEFs (AMPKα KO) were treated with 25mM 2-DG in glucose-free medium for 4 
hours. Endogenous YAP was immunoprecipitated (IP) and immunoblotted with indicated 
antibodies. (F) AMPK did not noticeably affect YAP phosphorylation at S127 site. (G) 2-
DG–induced LATS1 kinase activation was observed in both WT and AMPKα KO MEFs. 
MEF cells were treated with 25 mM 2-DG in glucose-free medium for 4 hours. Endogenous 
LATS1 was immunoprecipitated and subjected to in vitro kinase assay with GST-YAP (2 
μg) as substrate. (H) S61 was not the major phosphorylation site for LATS kinase. The 
Hippo pathway kinase complex (Myc-LATS2, HA-MOB1, HA-MST2 and HA-SAV1) was 
co-expressed with YAP-4SA-61S or YAP-4SA-127S mutant in 293T cells. (I) 
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Phosphorylation of S61 suppressed YAP transcriptional activity. The transcripts of CTGF 
and CYR61 were detected in indicated YAP-stable cells by quantitative PCR (mean±s.d, n=3 
biological replicates). *** p<0.001 (Student t-test). (J) AMPK suppressed YAP 
transcriptional activity. The transcription of YAP downstream genes was examined in WT 
and AMPKα KO MEF cells by quantitative PCR (mean, n=2 biological replicates). (K) Loss 
of AMPK partially rescued YAP activity in 2-DG–treated MEF cells. WT and AMPKα KO 
MEF cells were mock-treated or treated with 25 mM 2-DG in glucose-free medium for 4 
hours. YAP downstream genes were examined by quantitative PCR (mean, n=2 biological 
replicates) and normalised to untreated cells. Statistics source data are shown in 
Supplementary Table 2. Uncropped images of Western blots are shown in Supplementary 
Figure 7.
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Figure 5. Energy stress increases LATS kinase activation independent of MST kinases
(A–B) 2-DG treatment activated LATS1 but not MST1. HEK293A cells stably expressing 
SFB-LATS1 (A) or MST1 (B) were treated with 2-DG (25 mM) in glucose-free medium for 
4 hours, and cell lysates were subjected to Western blotting. (C) LATS1 activation 
decreased in cells released from various energy stresses (glucose starvation, AICAR, 2-DG 
as described for Figure 2B). Lysates of cells under energy stress (S) or released from energy 
stress for 1 hour (R) were subjected to Western blotting. (D) LATS kinases but not MST 
kinases were required for 2-DG–induced YAP S127 phosphorylation. LATS1/2-double 
knockout cells (KO) and MST1/2-double knockout cells were treated with 2-DG (25 mM) in 
glucose-free medium for 4 hours. Cell lysates were subjected to Western blotting. (E) Actin 
cytoskeleton and Rho GTPase were necessary for the decrease of YAP phosphorylation in 
cells released from energy stress. Cells under energy stress (glucose starvation, AICAR, 2-
DG) were pretreated with actin depolymeriser latrunculin B (1 μg/mL) for 30 minutes or 
Rho protein inhibitor C3 (2 μg/mL) for 2 hours and released from energy stress for 1 hour. 
Cell lysates were subjected to Western blotting. (F) Rho GTPase activation increased in 
cells released from energy stress. Indicated cell lysates were subjected to GST pulldown 
assay with GST-Rhotekin-RBD (Rho binding domain; 2 μg). GTP-formed RhoA in the 
pulldown samples, as well as the input controls, was detected by RhoA antibody. Uncropped 
images of Western blots are shown in Supplementary Figure 7.
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Figure 6. YAP regulates GLUT3 transcription in the glucose metabolic pathway
(A–B) YAP activity increased the acidification of cell culture medium. The colour of the 
medium (A) varied in the same-time cultures of the indicated YAP-stable cell lines. The pH 
was measured (B) in cultures of the indicated YAP-stable cell lines (mean±s.d, n=3 
biological replicates). * p<0.05 and *** p<0.001 (Student t-test). (C–D) YAP-5SA mutation 
promotes glycolysis. 2-NBDG uptake (C) and lactate production (D) were examined in 
indicated YAP stable cells (mean±s.d, n=3 biological replicate) as described in Methods. * 
p<0.05 and *** p<0.001 (Student t-test). (E) GLUT3 was identified as a YAP-regulated 
gene. The transcripts of glucose metabolism–related genes were detected by quantitative 
PCR in YAP-5SA cells and control vector–transfected cells. Fold increases are shown 
(mean, n=2 biological replicates). (F–H) The control of GLUT3 transcription by YAP was 
confirmed in various cell lines by quantitative PCR (mean±s.d, n=3 biological replicates). 
** p<0.01 and *** p<0.001 (Student t-test). (I and J) YAP increased the level of GLUT3 
protein in various cell lines. (K–L) Loss of YAP attenuated the increased GLUT3 expression 
in cells released from 16 hours of glucose starvation. The downregulation of YAP protein 
was confirmed by Western blotting (K). The transcription of GLUT3, AMOTL2 and CYR61 
was detected by quantitative PCR in cells under glucose starvation or released from glucose 
starvation for 2 hours and normalised (mean±s.d, n=3 biological replicates). (M) GLUT3 
was knockdown in YAP-5SA HEK293A cells by two different GLUT3 shRNAs. (N–O) 
GLUT3 knockdown suppressed the acidification of YAP-5SA cell medium. The colour of 
the medium varied in the cultures of the indicated cell lines (N). The pH was measured in 
the indicated cells (mean±s.d, n=3 biological replicates) (O). *** p<0.001 (Student t-test). 
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(P–Q) Knockdown of GLUT3 suppressed YAP-5SA–induced glycolysis. 2-NBDG uptake 
(P) and lactate production (Q) were examined (mean±s.d, n=3 biological replicates) as 
described in Methods. ** p<0.01 and *** p<0.001 (Student t-test). Statistics source data are 
shown in Supplementary Table 2. Individual data are plotted for Figures 6B, 6C, 6D, 6O, 6P 
and 6Q. Uncropped images of Western blots are shown in Supplementary Figure 7.
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Figure 7. YAP and GLUT3 expression positively correlate with each other in human colon and 
liver cancers
(A) Representative normal colon and colon carcinoma specimens and normal liver and liver 
carcinoma specimens in tissue arrays were subjected to immunohistochemical staining of 
YAP and GLUT3. Brown staining indicates positive immunoreactivity. The region in each 
box is enlarged below. Scale bar=30 μm. (B) Correlations between YAP and GLUT3 protein 
levels in human colon and liver tumours were analysed. Statistical significance was 
determined by the chi-square test; R: correlation coefficient.
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